Evorpacept Alone and in Combination with Pembrolizumab or Trastuzumab in Patients with Advanced Solid Tumors (ASPEN-01): a First-in-Human, Open-Label, Multicentre, Phase 1 Dose-Escalation and Dose-Expansion Study